Ferrer inCode SL-Product Pipeline Analysis, 2017 Update
April 2017
22
About the Report
About the Report
Summary
Ferrer inCode SL (Ferrer), a subsidiary of Grupo Ferrer Internacional SA is a provider of molecular diagnostics and personalized medicine solutions. The company offers biotechnological solutions to make clinical decisions for patients. Its products comprise microarray-based gene expression test, multigene profile, prognosis and predictive tool, expression panel, diagnostic tools and others. Ferrer promotes and grants access to personalized medicine through prognosis, diagnosis, and prediction based in genomics, proteomics, metabolomics, and bioinformatics technology. The company offers treatment for oncological, cardiovascular and CNS diseases. Ferrer is headquartered in Barcelona, Spain.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Ferrer inCode SL
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Products
Products
Ferrer inCode SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Ferrer inCode SL Company Overview 4
Ferrer inCode SL Company Snapshot 4
Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4
Ferrer inCode SL-Pipeline Analysis Overview 7
Ferrer inCode SL-Key Facts 7
Ferrer inCode SL-Major Products and Services 8
Ferrer inCode SL Pipeline Products by Development Stage 9
Ferrer inCode SL Pipeline Products Overview 11
DAP 11
DAP Product Overview 11
FAB-118 12
FAB-118 Product Overview 12
StrokeChip 13
StrokeChip Product Overview 13
VHC-Core 14
VHC-Core Product Overview 14
Ferrer inCode SL-Key Competitors 15
Ferrer inCode SL-Key Employees 16
Ferrer inCode SL-Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Ferrer inCode SL, Recent Developments 18
Aug 27, 2016: The first epigenetic test to identify tumors of unknown primary 18
Appendix 19
Methodology 19
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Figure
List of Figures
Ferrer inCode SL Pipeline Products by Equipment Type 5
Ferrer inCode SL Pipeline Products by Development Stage 9
List of Table
List of Tables
Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4
Ferrer inCode SL Pipeline Products by Equipment Type 5
Ferrer inCode SL Pipeline Products by Indication 6
Ferrer inCode SL, Key Facts 7
Ferrer inCode SL, Major Products and Services 8
Ferrer inCode SL Number of Pipeline Products by Development Stage 9
Ferrer inCode SL Pipeline Products Summary by Development Stage 10
DAP-Product Status 11
DAP-Product Description 11
FAB-118-Product Status 12
FAB-118-Product Description 12
StrokeChip-Product Status 13
StrokeChip-Product Description 13
VHC-Core-Product Status 14
VHC-Core-Product Description 14
Ferrer inCode SL, Key Employees 16
Glossary 20
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.